SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006293
Filing Date
2021-05-06
Accepted
2021-05-06 17:16:02
Documents
78
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ymab-20210331x10q.htm   iXBRL 10-Q 1772057
2 EX-10.7 ymab-20210331xex10d7.htm EX-10.7 31733
3 EX-31.1 ymab-20210331xex31d1.htm EX-31.1 15725
4 EX-31.2 ymab-20210331xex31d2.htm EX-31.2 15633
5 EX-32.1 ymab-20210331xex32d1.htm EX-32.1 7785
6 EX-32.2 ymab-20210331xex32d2.htm EX-32.2 7742
  Complete submission text file 0001558370-21-006293.txt   6656679

Data Files

Seq Description Document Type Size
7 EX-101.SCH ymab-20210331.xsd EX-101.SCH 49852
8 EX-101.CAL ymab-20210331_cal.xml EX-101.CAL 41221
9 EX-101.DEF ymab-20210331_def.xml EX-101.DEF 186238
10 EX-101.LAB ymab-20210331_lab.xml EX-101.LAB 455048
11 EX-101.PRE ymab-20210331_pre.xml EX-101.PRE 361417
12 EXTRACTED XBRL INSTANCE DOCUMENT ymab-20210331x10q_htm.xml XML 956149
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38650 | Film No.: 21898961
SIC: 2834 Pharmaceutical Preparations